Steven W. Pipe, MD; Stacy E. Croteau, MD, MMS; Andrew D. Leavitt, MD 

Community Practice Connections™: New Horizons in Hemophilia: Preparing for the Advent of Gene Therapy

Exploring the Advancements of Evidence-Based Testing and Treatment Strategies in CLL

James L. M. Ferrara, MD, DSc; Carrie Lynn Kitko, MD; Stephanie Lee, MD, MPH; Mark A. Schroeder, MD, MSCI

How We Do It™: Leveraging Novel Therapies and Patient Data to Inform Key Decisions in GvHD

Evolving Treatment Strategies for Adjuvant and Metastatic Melanoma: A Multidisciplinary Approach to Care

Joyce O’Shaughnessy, MD; David Euhus, MD; Tiffany A. Traina, MD; Joseph A. Sparano, MD

 School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

Srdan Verstovsek, MD, PhD; Andrew Kuykendall, MD; Lindsey Lyle, PA-C, MS; Laura Michaelis, MD; Abdulraheem Yacoub, MD

Community Practice Connections: DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We, and Where Are We Going?

Thomas D. Coates, MD; Paul C. Adams, MD; Tomas Ganz, PhD, MD; Janet L. Kwiatkowski, MD, MSCE

Optimizing Management of Iron Overload: Strategies to Improve Identification and Treatment

Exploring Strategies for Treating Solid Tumors With PARP Inhibitors

Hope S. Rugo, MD, FASCO; William J. Gradishar, MD, FASCO, FACP; Komal Jhaveri, MD, FACP; Sara M. Tolaney, MD, MPH; Debu Tripathy, MD 

Medical Crossfire®: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer

Suresh S. Ramalingam, MD, FACP,  FASCO, Keith Kerr, BSc, MBChB, FRCPath, FRCPE, Luis Paz-Ares, MD, PhD, Solange Peters, MD, PhD, Tony Mok, MD, FRCPC, FASCO

PER Global® Virtual Tumor Board: EGFR Mutation Matters: Optimizing Therapy by EGFR Mutation Subtype and Co-Mutations

Javier Pinilla-Ibarz, MD, PhD; Jacqueline C. Barrientos, MD, MS; Catherine C. Coombs, MD; Nilanjan Ghosh, MD, PhD

Medical Crossfire®: How Can We Maximize Outcomes With PI3K Inhibitors Across Hematologic Malignancies?

Ifeyinwa Osunkwo, MD, MPH; Biree Andemariam, MD; Bernard L Lopez, MD, MS, CPE

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

Craig M. Kessler, MD, MACP; Cindy Leissinger, MD; Steven W. Pipe, MD

Managing the Whole Patient with Hemophilia A: Clinical Evidence and Practical Strategies

Community Practice Connections™: 16th Annual New York Lung Cancers Symposium®

Manish J. Butte, MD, PhD; Jolan Walter, MD, PhD

  Clinical Consultations™: Raising Awareness and Optimizing Treatment in Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)

Jeff Gudin, MD; Meroë B. Morse, MD, ABOIM; Robert Bonakdar, MD, FAAFP, FACN; Suzanne Manzi, MD; Nidal Moukaddam, MD, PhD; Stacy V. Smith, MD; Wajeeha Yousaf, MD

Evolving Approaches in Pain Management

Josh Kosowsky, MD, FACEP; Natalie Kreitzer, MD, MS; Jose I. Suarez, MD, FNCS, FANA, FAAN


Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

Onye J. Ononogbu, PharmD, BCOP; Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP, FAAN; Ana Maria Lopez, MD, MPH, MACP, FRCP; Susan Fugett, MSW, LISW-S, OSW-C, CSW-G

  Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

Colleen Cotton, MD, FAAD; Raj Chovatiya, MD, PhD, FAAD

Addressing Challenges in the Management of HS in Special Populations

Best Practice in the Multidisciplinary Care of the Patient with HS

Robert Z. Orlowski, MD, PhD; Elisabet E. Manasanch, MD, MHSc; Jing Christine Ye, MD, MSc

Clinical Vignettes: Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Charu Aggarwal, MD, MPH; David R. Gandara, MD; Lynette M. Sholl, MD; Ignacio I. Wistuba, MD

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Heather A. Wakelee, MD, FASCO; Lyudmila Bazhenova, MD; Kristin Higgins, MD; Brendon Stiles, MD

  Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

Jessica Ailani, MD, FAHS, FAAN; Richard S. Isaacson, MD; Stephen Krieger, MD, FAAN; Rory Abrams, MD; Karthikeyan M. Arcot, MD; Cynthia E. Armand, MD; Patricia K. Coyle, MD; Gayatri Devi, MD, MS, FAAN; 

2022 4th Annual International Congress on the Future of Neurology

Johanna P. Contreras, MD, MSc, FACC, FAHA, FHFSA; Melvin R. Echols, MD, FACC, FHFSA, FASPC

Clinical Consultations: Improving Outcomes By Addressing Health Care Disparities in Heart Failure Care

Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older

Antibody-Drug Conjugates in Gynecological Cancer: Review of the Clinical Data

Grace Cherry, MSN, RN, NP; Beth Sandy, MSN, CRNP; Laura S. Wood, MSN, RN, OCN; Patricia Mangan, MSN, RN, CRNP, APRN-BC; Kimberly Podsada, MSN, NP-C; Rowena “Moe” Schwartz, PharmD, BCOP,
FHOPA



Community Practice Connections™: 6th Annual School of Nursing Oncology

David R. Gandara, MD; Roy S. Herbst, MD, PhD; Natasha B. Leighl, MD, MMSc, FRCPC, FASCO; Heather A. Wakelee, MD

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

Hope S. Rugo, MD, FASCO; Giuseppe Curigliano, MD, PhD; Özge Gümüşay, MD

  Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

Srdan Verstovsek, MD, PhD; Lucia Masarova, MD; Jeanne Palmer, MD; Abdulraheem Yacoub, MD   

Medical Crossfire®:  Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

John Mascarenhas, MD; Heinz Gisslinger, MD; Kathryn Johnson, DNP, MSc, FNP-BC; Naveen Pemmaraju, MD


4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Edward B. Garon, MD, MS; Rebecca Heist, MD, MPH; Solange Peters, MD, PhD; Jacob Sands, MD

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Bruce Ovbiagele, MD MSc MAS MBA MLS; Alexis N. Simpkins, MD, PhD, MSCR, FAHA; Charles Esenwa, MD, MS

Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?

Tahseen Mozaffar, MD; Allison Foley, MS, CGC; Perry B. Shieh, MD, PhD

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

Scott Urquhart, PA-C, DFAAPA; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It?

Marwan N. Sabbagh, MD, FAAN; Richard S. Isaacson, MD; Lon Schneider, MD, MS

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

Steven Horwitz, MD; Ellen J. Kim, MD; Alison Moskowitz. MD

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

Shakeel Modak, MD, MRCP; Araz Marachelian, MD, MS

Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases

Stephen Krieger, MD, FAAN; Erin Longbrake, MD, PhD

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

Scott Urquhart, PA-C, DFAAPA; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Kim Zuber, PA-C

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Lynette M. Sholl, MD; Justin F. Gainor, MD; Fred R. Hirsch, MD, PhD, FASCO

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

J. William Harbour, MD; Richard D. Carvajal, MD; Alison H. Skalet, MD, PhD

Medical Crossfire®: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD, DFAPA; Larry Culpepper, MD; Corine de Boer, MD, PhD; Rif S. El-Mallakh, MD; C. Neill Epperson, MD; Marlene P. Freeman, MD; Nassir Ghaemi, MD, MPH; Joseph F. Goldberg, MD; Benjamin D. Greenberg, MD, PhD; Mark B. Hamner, MD; Brian Hurley, MD, MBA, DFASAM; Alana Iglewicz, MD; Jonathan M. Meyer, MD; Nidal Moukaddam, MD, PhD; Sonya Norman, PhD; Edward Nunes, MD; Dhakshin Ramanathan, MD, PhD; Christopher Schneck, MD; M. Katherine Shear, MD; Michael E. Thase, MD; J. Eric Vance, MD; David B. Yaden, PhD; Rachel Yehuda, PhD; Sidney Zisook, MD

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

Elucidating Novel BTKi Strategies in CLL/SLL and MCL: A Virtual Exploration to Bring Therapeutic Rationales and Evidence into Perspective

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

Abbey Kaler, MS, APRN, FNP-C; Kelly Leonard, MSN, APRN, FNP-BC

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Neil M. Bressler, MD; Jennifer I. Lim, MD, FARVO

(COPE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

(CME/CNE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Jennifer Dvorak, MSN, FNP-BC; Beth Sandy, MSN, CRNP

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

Neal Shore, MD, FACS; Scott Tagawa, MD, MS, FACP

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

Arshad M. Khanani MD, MA; Jennifer I. Lim MD, FARVO, FASRS

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

Elias Jabbour, MD; Hagop M. Kantarjian, MD

Community Practice Connections™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Joyce O’Shaughnessy, MD; Balazs Halmos, MD, MS; Cathy Eng, MD, FACP, FASCO;  Brian I. Rini, MD, FASCO; Saad Z. Usmani, MD, MBA, FACP; Nilanjan Ghosh, MD, PhD

  Community Practice Connections™: ASCO Direct Highlights: Practice-Changing Data From the Leading Oncology Conference

Jason J. Luke, MD, FACP; Evan J. Lipson, MD; Yana G. Najjar, MD; Daniel Olson, MD; Sapna Patel, BA, MD

  Medical Crossfire ®: Addressing the Top 10 Clinical Challenges in Melanoma

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP, OCN 

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

Ticiana A. Leal, MD; Jordyn P. Higgins, PharmD, BCOP; Ashley Rollins, BSN, OCN

Patient, Provider, and Caregiver Connection™: Shedding a Light on the Patient Journey with KRAS Mutated Lung Cancer

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Matthew Galsky, MD, FASCO; Kevin Kalinsky, MD, MS; Samuel J. Klempner, MD

Community Practice Connections™: 6th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Arshad M. Khanani, MD, MA; Peter K. Kaiser, MD; Anat Loewenstein, MD, MHA; Christina Y. Weng, MD, MBA, FASRS

Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Neil M. Bressler, MD; Sophie J. Bakri, MD, MBA; Jennifer I. Lim, MD, FARVO

Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Mile Brujic, OD, FAAO; Marc R. Bloomenstein, OD, FAAO; Selina McGee, OD, FAAO

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

Naval G. Daver, MD ; Guillermo Garcia-Manero, MD ; Uma Borate, MD, MS ; Jacqueline S. Garcia, MD 

Clinical Vignettes: Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Expert Illustrations & Commentaries™: Exploring the Role of Novel Antibody-Drug Conjugates in Advanced NSCLC

BURST Expert Illustrations & Commentaries™: Personalizing Treatment Regimens for Patients with Hemophilia

Laura S. Wood RN, MSN, OCN; Kathleen D. Burns, MSN, AGACNP-BC, OCN; Michael E Seabright Jr, PharmD, BCOP

Show Me Your Care Plan! Developing Multidisciplinary Strategies to Optimize the First-Line Care of Patients with mRCC

Bradley J. Monk, MD, FACS, FACOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Community Practice Connections®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Elizabeth (Ebbie) Stewart, MD; Hugh Taylor, MD; Homa K. Ahmadzia, MD, MPH; Alyssa Brown, MD; Isabel C. Green, MD; Cynthia Gyamfi-Bannerman, MD, MS; Michael J. Joyner, MD; Amanda N. Kallen, MD, FACOG; Beth Y. Karlan, MD; Heather S. Lipkind, MD, MS; Judette Louis, MD, MPH; JoAnn V. Pinkerton, MD, FACOG, NCMP; Nancy Ringel, MD, MS; Nanette Santoro, MD; Moeun Son, MD, MSCI, FACOG

3rd Annual International Congress on the Future of Women’s Health™

Broadening the Impact of Adjuvant Immunotherapy in Melanoma 

Ophthalmology Consultations™: Keeping an Eye Out for MGD-Associated Dry Eye in Pre/Post-Op Patients – Improving Surgical Outcomes by Optimizing the Surface

Arshad M. Khanani, MD, MA; Anat Loewenstein, MD, MHA

Community Practice Connections™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Hanny Al-Samkari, MD; Kevin H.M. Kuo, MD, MSc, FRCPC; Sujit Sheth, MD

Medical Crossfire®: Strategies to Manage Transfusional Iron Overload in Patients with ß-hemoglobinopathies: Optimizing Patient Outcomes

Edgardo S. Santos, MD, FACP; Julia Rotow, MD

Advances In™ NSCLC: Exploring CEACAM5 As A New Therapeutic Target

Kenneth C. Anderson, MD; Elias Jabbour, MD; Gilles A. Salles, MD, PhD

Community Practice Connections™: 6th Annual Live Medical Crossfire®: Hematologic Malignancies 

Daniel C. Brennan, MD, FACP; Stanley C. Jordan, MD; Yousuf Kyeso, MD; Bonnie Lonze, MD, PhD

Community Practice Connections™: Expert Approaches to Preventing Graft Failure in Renal Transplant Recipients 

Megan Hinkley, PharmD, BCOP; Meg Taylor, PharmD, CPP

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Emanuele Zucca, MD; Massimo Federico, MD; Pier Luigi Zinzani, MD, PhD 

Medical Crossfire®: How the Experts Manage Advanced HL and PTCL in the Real World from Frontline to R/R Treatment Settings

Brett King, MD, PhD; Brittany Craiglow, MD

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

Updates From the Annual Hematology Meeting: Matching the Tumor With Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

Follicular Lymphoma Workshop: Forging Patient-Centric Plans With Targeted Therapies Across Lines of Care

Reflective Case-Based Oncology Collective™: Translating Recent Evidence on CAR T Cell Therapy to the Real-World Management of Lymphoid Malignancies

Reflective Case Based Oncology Collective™: Incorporating Novel HER2- Targeted Therapies into Treatment Algorithms Across Metastatic Breast Cancer

22nd Annual International Congress on the Future of Breast Cancer® West

Reflective Case-Based Oncology Collective™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Scott Tagawa, MD, MS, FACP; Alicia Morgans, MD, MPH; Michael J. Morris, MD

Continuing Education